Tenofovir-Related Fanconi Syndrome with Nephrogenic Diabetes Insipidus in a Patient with Acquired Immunodeficiency Syndrome: The Role of Lopinavir-Ritonavir-Didanosine
Open Access
- 15 December 2003
- journal article
- case report
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 37 (12) , e174-e176
- https://doi.org/10.1086/379829
Abstract
Tenofovir-related tubular damage, like all other recently reported cases, occurred in patients receiving the protease inhibitor (PI) ritonavir, oftenKeywords
This publication has 11 references indexed in Scilit:
- Tenofovir‐Related Nephrotoxicity in Human Immunodeficiency Virus–Infected Patients: Three Cases of Renal Failure, Fanconi Syndrome, and Nephrogenic Diabetes InsipidusClinical Infectious Diseases, 2003
- Fatal Lactic Acidosis and Acute Renal Failure after Addition of Tenofovir to an Antiretroviral Regimen Containing DidanosineClinical Infectious Diseases, 2003
- Renal lesions in HIV-1-positive patient treated with tenofovirAIDS, 2003
- Drug-induced Fanconi's syndromeAmerican Journal of Kidney Diseases, 2003
- Fanconi syndrome and renal failure induced by tenofovir: A first case reportAmerican Journal of Kidney Diseases, 2002
- Tenofovir DF in antiretroviral-experienced patients: results from a 48-week, randomized, double-blind studyAIDS, 2002
- Molecular Aspects of Renal Anionic Drug TransportAnnual Review of Physiology, 2002
- Ritonavir induces P-glycoprotein expression, multidrug resistance-associated protein (MRP1) expression, and drug transporter-mediated activity in a human intestinal cell lineJournal of Pharmaceutical Sciences, 2001
- Interactions of HIV Protease Inhibitors with ATP-Dependent Drug Export ProteinsMolecular Pharmacology, 1999
- Estimating HIV prevalence in SwitzerlandAIDS, 1993